Comparison of concurrent chemoradiotherapy followed by immunotherapy and induction chemoimmunotherapy followed by radiotherapy in unresectable stage III NSCLC: a retrospective cohort study. | Synapse
March 2, 20260 citations
Comparison of concurrent chemoradiotherapy followed by immunotherapy and induction chemoimmunotherapy followed by radiotherapy in unresectable stage III NSCLC: a retrospective cohort study.
To compare the effectiveness and safety of concurrent chemoradiotherapy followed by immunotherapy versus induction chemoimmunotherapy followed by radiotherapy in unresectable stage III NSCLC.
Conducted a retrospective cohort study
Analyzed patient outcomes post-treatment
Compared cCRT+IO and ICT+RT
cCRT+IO showed superior efficacy compared to ICT+RT
Safety profile of cCRT+IO was manageable
Significant improvement in treatment outcomes with cCRT+IO
Abstract
Compared with ICT+RT, cCRT+IO demonstrated superior efficacy with a manageable safety profile in unresectable stage III NSCLC.